Daniëlle de Jong

3.8k total citations
71 papers, 2.6k citations indexed

About

Daniëlle de Jong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Daniëlle de Jong has authored 71 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 19 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Daniëlle de Jong's work include Sarcoma Diagnosis and Treatment (16 papers), Bone Tumor Diagnosis and Treatments (11 papers) and Alzheimer's disease research and treatments (9 papers). Daniëlle de Jong is often cited by papers focused on Sarcoma Diagnosis and Treatment (16 papers), Bone Tumor Diagnosis and Treatments (11 papers) and Alzheimer's disease research and treatments (9 papers). Daniëlle de Jong collaborates with scholars based in Netherlands, United States and Australia. Daniëlle de Jong's co-authors include Károly Szuhai, Pancras C.W. Hogendoorn, Marcel M. Verbeek, Judith V.M.G. Bovée, R.W.M.M. Jansen, Daniëlle Meijer, Berry Kremer, Sofie Verbeke, Hannie Kremer and Marcel G. M. Olde Rikkert and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Nature Genetics.

In The Last Decade

Daniëlle de Jong

71 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniëlle de Jong Netherlands 29 847 778 449 445 413 71 2.6k
Laurent Martin France 32 699 0.8× 568 0.7× 247 0.6× 515 1.2× 218 0.5× 156 2.9k
Shiro Saito Japan 32 991 1.2× 986 1.3× 316 0.7× 562 1.3× 217 0.5× 261 3.8k
Hiroshi Takahashi Japan 29 537 0.6× 962 1.2× 186 0.4× 454 1.0× 218 0.5× 173 3.2k
Koji Inoue Japan 29 638 0.8× 677 0.9× 345 0.8× 677 1.5× 151 0.4× 183 2.7k
Murim Choi South Korea 35 3.2k 3.8× 465 0.6× 272 0.6× 438 1.0× 309 0.7× 112 5.9k
Kenjiro Kosaki Japan 35 2.7k 3.2× 565 0.7× 388 0.9× 362 0.8× 172 0.4× 363 5.2k
Armin E. Heufelder Germany 43 1.7k 2.0× 173 0.2× 361 0.8× 774 1.7× 515 1.2× 113 5.7k
Anna Petryk United States 36 2.4k 2.8× 266 0.3× 474 1.1× 467 1.0× 406 1.0× 126 6.0k
Pascale Marcorelles France 29 762 0.9× 311 0.4× 191 0.4× 498 1.1× 424 1.0× 138 2.6k
Sture Falkmer Sweden 45 1.5k 1.8× 992 1.3× 223 0.5× 1.7k 3.8× 585 1.4× 244 6.4k

Countries citing papers authored by Daniëlle de Jong

Since Specialization
Citations

This map shows the geographic impact of Daniëlle de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniëlle de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniëlle de Jong more than expected).

Fields of papers citing papers by Daniëlle de Jong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniëlle de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniëlle de Jong. The network helps show where Daniëlle de Jong may publish in the future.

Co-authorship network of co-authors of Daniëlle de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Daniëlle de Jong. A scholar is included among the top collaborators of Daniëlle de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniëlle de Jong. Daniëlle de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jong, Daniëlle de, et al.. (2024). Interplay of Ritonavir-Boosted Oral Cabazitaxel with the Organic Anion-Transporting Polypeptide (OATP) Uptake Transporters and Carboxylesterase 1 in Mice. Molecular Pharmaceutics. 21(4). 1952–1964. 1 indexed citations
2.
Hooij, Anouk van, Zijie Zhou, Daniëlle de Jong, et al.. (2023). Development of lateral flow assays to detect host proteins in cattle for improved diagnosis of bovine tuberculosis. Frontiers in Veterinary Science. 10. 1193332–1193332. 4 indexed citations
3.
Jong, Daniëlle de, et al.. (2023). Enhancement of the Oral Availability of Cabazitaxel Using the Cytochrome P450 3A (CYP3A) Inhibitor Ritonavir in Mice. Molecular Pharmaceutics. 20(5). 2477–2489. 2 indexed citations
4.
Jansen, Floor E., Charlotte W. Ockeloen, Marjan J. A. van Kempen, et al.. (2023). Epilepsy is an important feature of KBG syndrome associated with poorer developmental outcome. Epilepsia Open. 8(4). 1300–1313. 7 indexed citations
5.
Malaviya, Paritosh, Anouk van Hooij, Shyam Sundar, et al.. (2023). Field-friendly anti-PGL-I serosurvey in children to monitor Mycobacterium leprae transmission in Bihar, India. Frontiers in Medicine. 10. 1260375–1260375. 6 indexed citations
6.
Jong, Daniëlle de, Maria C. Lebre, Hilde Rosing, et al.. (2021). P-Glycoprotein (ABCB1/MDR1) Controls Brain Penetration and Intestinal Disposition of the PARP1/2 Inhibitor Niraparib. Molecular Pharmaceutics. 18(12). 4371–4384. 13 indexed citations
7.
Sánchez‐Duffhues, Gonzalo, Harald Mikkers, Daniëlle de Jong, et al.. (2019). Generation of Fibrodysplasia ossificans progressiva and control integration free iPSC lines from periodontal ligament fibroblasts. Stem Cell Research. 41. 101639–101639. 4 indexed citations
8.
Ramialison, Mirana, Ashley J. Waardenberg, Nicole Schönrock, et al.. (2017). Analysis of steric effects in DamID profiling of transcription factor target genes. Genomics. 109(2). 75–82. 5 indexed citations
9.
Ven, Robert A. H. van de, Danielle Park, Robert van Domselaar, et al.. (2016). p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis. Nature Communications. 7(1). 13874–13874. 22 indexed citations
10.
Jong, Yvonne de, Adrián Mariño‐Enríquez, Daniëlle de Jong, et al.. (2016). Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell line. Laboratory Investigation. 96(10). 1128–1137. 27 indexed citations
11.
Bouveret, Romaric, Ashley J. Waardenberg, Nicole Schönrock, et al.. (2015). NKX2-5 mutations causative for congenital heart disease retain functionality and are directed to hundreds of targets. eLife. 4. 58 indexed citations
12.
Meijer, Daniëlle, Daniëlle de Jong, Twinkal C. Pansuriya, et al.. (2012). Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma. Genes Chromosomes and Cancer. 51(10). 899–909. 73 indexed citations
13.
Andrea, Carlos E. de, Christianne M. A. Reijnders, Herman M. Kroon, et al.. (2011). Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT. Oncogene. 31(9). 1095–1104. 51 indexed citations
14.
Szuhai, Károly, Marije IJszenga, Daniëlle de Jong, et al.. (2009). The NFATc2 Gene Is Involved in a Novel Cloned Translocation in a Ewing Sarcoma Variant That Couples Its Function in Immunology to Oncology. Clinical Cancer Research. 15(7). 2259–2268. 154 indexed citations
15.
Hertel, Jana, Daniëlle de Jong, Manja Marz, et al.. (2009). Non-coding RNA annotation of the genome of Trichoplax adhaerens. Nucleic Acids Research. 37(5). 1602–1615. 50 indexed citations
16.
Nijmeijer, Bart, Károly Szuhai, Henriëtte M. Goselink, et al.. (2009). Long–term culture of primary human lymphoblastic leukemia cells in the absence of serum or hematopoietic growth factors. Experimental Hematology. 37(3). 376–385. 52 indexed citations
17.
Brinkman, Arend, et al.. (2009). The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells. Breast Cancer Research and Treatment. 120(2). 401–408. 17 indexed citations
18.
Jong, Daniëlle de, Berry Kremer, Marcel G. M. Olde Rikkert, & Marcel M. Verbeek. (2007). Current state and future directions of neurochemical biomarkers for Alzheimer's disease. Clinical Chemistry and Laboratory Medicine (CCLM). 45(11). 1421–34. 64 indexed citations
19.
Zandwijk, Nico van, Alexandre Mathy, Lucie Boerrigter, et al.. (2006). EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer. Annals of Oncology. 18(1). 99–103. 123 indexed citations
20.
Abdo, Wilson F., Daniëlle de Jong, Jan C.M. Hendriks, et al.. (2003). Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease. Movement Disorders. 19(5). 571–579. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurent Martin Breakdown of academic impact, for papers by Shiro Saito Breakdown of academic impact, for papers by Hiroshi Takahashi Breakdown of academic impact, for papers by Koji Inoue Breakdown of academic impact, for papers by Murim Choi Breakdown of academic impact, for papers by Kenjiro Kosaki Breakdown of academic impact, for papers by Armin E. Heufelder Breakdown of academic impact, for papers by Anna Petryk Breakdown of academic impact, for papers by Pascale Marcorelles Breakdown of academic impact, for papers by Sture Falkmer
Rankless by CCL
2026